KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Revenue (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Revenue for 11 consecutive years, with $400000.0 as the latest value for Q4 2025.

  • Quarterly Revenue fell 99.48% to $400000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $239.7 million through Dec 2025, down 15.43% year-over-year, with the annual reading at $322.7 million for FY2025, 13.83% up from the prior year.
  • Revenue hit $400000.0 in Q4 2025 for Fulgent Genetics, down from $84.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $359.4 million in Q1 2021 to a low of $400000.0 in Q4 2025.
  • Historically, Revenue has averaged $124.0 million across 5 years, with a median of $81.8 million in 2025.
  • Biggest five-year swings in Revenue: soared 4536.0% in 2021 and later crashed 99.48% in 2025.
  • Year by year, Revenue stood at $251.7 million in 2021, then crashed by 58.02% to $105.7 million in 2022, then crashed by 33.27% to $70.5 million in 2023, then grew by 8.1% to $76.2 million in 2024, then plummeted by 99.48% to $400000.0 in 2025.
  • Business Quant data shows Revenue for FLGT at $400000.0 in Q4 2025, $84.1 million in Q3 2025, and $81.8 million in Q2 2025.